Gregory Mark Armour
Insider
First SEC filing: Feb. 14, 2008 · Latest: June 25, 2009
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 3, 2015 | IVZ | S | 25,000 | $40.41 | $1,010,250 | 383,018 Direct | -6.13% | Disposed | -24.1% (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | M | 22,486 | · | · | 22,486 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | M | 28,875 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | F | 37,799 | $40.27 | $1,522,166 | 408,018 Direct | -8.48% | Disposed | -23.9% (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | A | 5,138 | · | · | 445,817 Direct | +1.17% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | A | 4,899 | · | · | 440,679 Direct | +1.12% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | A | 7,061 | · | · | 435,780 Direct | +1.65% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | M | 22,486 | · | · | 428,719 Direct | +5.54% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | M | 28,875 | · | · | 406,233 Direct | +7.65% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2015 | IVZ | A | 56,741 | · | · | 377,358 Direct | +17.70% | Acquired | (price as of 2026-10-02) |
| March 11, 2014 | IVZ | S | 30,000 | $34.97 | $1,049,100 | 320,617 Direct | -8.56% | Disposed | -12.3% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 22,486 | · | · | 44,972 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 28,875 | · | · | 28,875 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 68,075 | · | · | 350,617 Direct | +24.09% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | F | 1,369 | $34.30 | $46,957 | 282,542 Direct | -0.48% | Disposed | -10.6% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 4,899 | · | · | 283,911 Direct | +1.76% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | F | 4,692 | $34.30 | $160,936 | 279,012 Direct | -1.65% | Disposed | -10.6% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | F | 1,973 | $34.30 | $67,674 | 283,704 Direct | -0.69% | Disposed | -10.6% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 7,061 | · | · | 285,677 Direct | +2.53% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | F | 6,281 | $34.30 | $215,438 | 278,616 Direct | -2.20% | Disposed | -10.6% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 22,486 | · | · | 284,897 Direct | +8.57% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | F | 8,065 | $34.30 | $276,630 | 262,411 Direct | -2.98% | Disposed | -10.6% (price as of 2026-10-02) |
| Feb. 28, 2014 | IVZ | M | 28,875 | · | · | 270,476 Direct | +11.95% | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2014 | IVZ | M | 37,245 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2014 | IVZ | F | 10,403 | $33.11 | $344,443 | 241,601 Direct | -4.13% | Disposed | -7.4% (price as of 2026-10-02) |
| Feb. 26, 2014 | IVZ | M | 37,245 | · | · | 252,004 Direct | +17.34% | Acquired | (price as of 2026-10-02) |
| Nov. 8, 2013 | IVZ | S | 50,000 | $32.89 | $1,644,500 | 214,759 Direct | -18.89% | Disposed | -6.8% (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | M | 22,485 | · | · | 67,458 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | M | 28,875 | · | · | 57,750 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | A | 67,189 | · | · | 264,759 Direct | +34.01% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | F | 1,342 | $26.79 | $35,952 | 197,570 Direct | -0.67% | Disposed | 14.4% (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | A | 7,061 | · | · | 198,912 Direct | +3.68% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | F | 4,273 | $26.79 | $114,474 | 191,851 Direct | -2.18% | Disposed | 14.4% (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | M | 22,485 | · | · | 196,124 Direct | +12.95% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | F | 5,487 | $26.79 | $146,997 | 173,639 Direct | -3.06% | Disposed | 14.4% (price as of 2026-10-02) |
| Feb. 28, 2013 | IVZ | M | 28,875 | · | · | 179,126 Direct | +19.22% | Acquired | (price as of 2026-10-02) |
| Feb. 27, 2013 | IVZ | M | 61,243 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 27, 2013 | IVZ | F | 10,338 | $26.44 | $273,337 | 150,251 Direct | -6.44% | Disposed | 16.0% (price as of 2026-10-02) |
| Feb. 27, 2013 | IVZ | M | 61,243 | $26.44 | $1,619,265 | 160,589 Direct | +61.65% | Acquired | 16.0% (price as of 2026-10-02) |
| Feb. 26, 2013 | IVZ | M | 37,245 | · | · | 37,245 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2013 | IVZ | F | 6,287 | $25.64 | $161,199 | 99,346 Direct | -5.95% | Disposed | 19.6% (price as of 2026-10-02) |
| Feb. 26, 2013 | IVZ | M | 37,245 | · | · | 105,633 Direct | +54.46% | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2012 | IVZ | S | 77,116 | $25.08 | $1,934,069 | 68,388 Direct | -53.00% | Disposed | 22.2% (price as of 2026-10-02) |
| Feb. 28, 2012 | IVZ | A | 89,943 | · | · | 89,943 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2012 | IVZ | M | 28,874 | · | · | 86,625 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2012 | IVZ | F | 11,391 | $24.96 | $284,319 | 145,504 Direct | -7.26% | Disposed | 22.8% (price as of 2026-10-02) |
| Feb. 28, 2012 | IVZ | M | 28,874 | · | · | 156,895 Direct | +22.55% | Acquired | (price as of 2026-10-02) |
| Feb. 27, 2012 | IVZ | M | 61,242 | · | · | 61,243 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 27, 2012 | IVZ | F | 24,160 | $24.77 | $598,443 | 128,021 Direct | -15.88% | Disposed | 23.8% (price as of 2026-10-02) |
| Feb. 27, 2012 | IVZ | M | 61,242 | · | · | 152,181 Direct | +67.34% | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2012 | IVZ | M | 37,245 | · | · | 74,490 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2012 | IVZ | F | 14,694 | $24.88 | $365,587 | 90,939 Direct | -13.91% | Disposed | 23.2% (price as of 2026-10-02) |
| Feb. 26, 2012 | IVZ | M | 37,245 | · | · | 105,633 Direct | +54.46% | Acquired | (price as of 2026-10-02) |
| March 2, 2011 | IVZ | S | 100,000 | $26.10 | $2,610,000 | 68,388 Direct | -59.39% | Disposed | 17.5% (price as of 2026-10-02) |
| Feb. 28, 2011 | IVZ | A | 115,499 | · | · | 115,499 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2011 | IVZ | F | 3,667 | $26.84 | $98,422 | 168,388 Direct | -2.13% | Disposed | 14.2% (price as of 2026-10-02) |
| Feb. 28, 2011 | IVZ | F | 43,221 | $26.84 | $1,160,052 | 172,055 Direct | -20.08% | Disposed | 14.2% (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | M | 37,244 | · | · | 111,735 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | M | 61,242 | · | · | 122,485 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | F | 15,811 | $26.40 | $417,410 | 215,276 Direct | -6.84% | Disposed | 16.1% (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | M | 37,244 | · | · | 231,087 Direct | +19.21% | Acquired | (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | F | 25,998 | $26.40 | $686,347 | 193,843 Direct | -11.83% | Disposed | 16.1% (price as of 2026-10-02) |
| Feb. 25, 2011 | IVZ | M | 61,242 | · | · | 219,841 Direct | +38.61% | Acquired | (price as of 2026-10-02) |
| Jan. 10, 2011 | IVZ | S 10b5-1 | 10,000 | $24.11 | $241,100 | 158,599 Direct | -5.93% | Disposed | 27.2% (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 5,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 30,980 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 10,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | S | 45,980 | $19.51 | $897,070 | 168,599 Direct | -21.43% | Disposed | 57.2% (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 30,980 | $12.76 | $395,305 | 214,579 Direct | +16.87% | Acquired | 140.3% (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 5,000 | $11.46 | $57,300 | 183,599 Direct | +2.80% | Acquired | 167.5% (price as of 2026-10-02) |
| Sept. 7, 2010 | IVZ | X | 10,000 | $9.77 | $97,700 | 178,599 Direct | +5.93% | Acquired | 213.8% (price as of 2026-10-02) |
| Feb. 28, 2010 | IVZ | M | 61,242 | · | · | 61,242 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 26, 2010 | IVZ | A | 148,979 | · | · | 148,979 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2010 | IVZ | F | 31,465 | $19.60 | $616,714 | 168,599 Direct | -15.73% | Disposed | 56.4% (price as of 2026-10-02) |
| Feb. 26, 2010 | IVZ | M | 61,242 | · | · | 200,064 Direct | +44.12% | Acquired | (price as of 2026-10-02) |
| July 1, 2009 | IVR | P | 5,000 | $20.00 | $100,000 | 5,000 Direct | · | Acquired | -97.1% (price as of 2026-10-02) |
| Feb. 27, 2009 | IVZ | A | 244,968 | · | · | 244,968 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 27, 2009 | IVZ | F | 5,468 | $11.43 | $62,499 | 138,822 Direct | -3.79% | Disposed | 168.2% (price as of 2026-10-02) |
| Jan. 30, 2009 | IVZ | F | 1,250 | $11.79 | $14,738 | 144,290 Direct | -0.86% | Disposed | 160.1% (price as of 2026-10-02) |
| Jan. 30, 2009 | IVZ | A | 1,616 | · | · | 145,540 Direct | +1.12% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2009 | IVZ | M | 1,616 | · | · | 143,924 Direct | +1.14% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2009 | IVZ | M | 1,616 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 30, 2009 | IVZ | F | 1,228 | $11.79 | $14,478 | 144,312 Direct | -0.84% | Disposed | 160.1% (price as of 2026-10-02) |
| Feb. 28, 2008 | IVZ | A | 127,730 | · | · | 142,308 Direct | +876.18% | Acquired | (price as of 2026-10-02) |
| Nov. 30, 2007 | IVZ | C | 2,680 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 30, 2007 | IVZ | C | 1,340 | · | · | 14,578 Direct | +10.12% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 28, 2015 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 22,486 | Disposed |
| Feb. 28, 2015 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 28,875 | Disposed |
| Feb. 28, 2014 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 22,486 | Disposed |
| Feb. 28, 2014 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 28,875 | Disposed |
| Feb. 26, 2014 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 37,245 | Disposed |
| Feb. 28, 2013 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 22,485 | Disposed |
| Feb. 28, 2013 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 28,875 | Disposed |
| Feb. 27, 2013 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 61,243 | Disposed |
| Feb. 26, 2013 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 37,245 | Disposed |
| Feb. 28, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 89,943 | Acquired |
| Feb. 28, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 28,874 | Disposed |
| Feb. 27, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 61,242 | Disposed |
| Feb. 26, 2012 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 37,245 | Disposed |
| Feb. 28, 2011 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 115,499 | Acquired |
| Feb. 25, 2011 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 37,244 | Disposed |
| Feb. 25, 2011 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 61,242 | Disposed |
| Sept. 7, 2010 | IVZ | Employee Stock Option (right to buy) | Common Shares | $11.46 | Dec. 15, 2013 | 5,000 | Disposed |
| Sept. 7, 2010 | IVZ | Employee Stock Option (right to buy) | Common Shares | $12.76 | Sept. 2, 2012 | 30,980 | Disposed |
| Sept. 7, 2010 | IVZ | Employee Stock Option (right to buy) | Common Shares | $9.77 | Dec. 30, 2014 | 10,000 | Disposed |
| Feb. 28, 2010 | IVZ | Deferred Share Award - Time Vesting | Common Shares | $0.00 | · | 61,242 | Disposed |
| Feb. 26, 2010 | IVZ | Restricted Stock Units [F2] | Common Shares | $0.00 | · | 148,979 | Acquired |
| Feb. 27, 2009 | IVZ | Restricted Stock Units [F1] | Common Shares | · | · | 244,968 | Acquired |
| Jan. 30, 2009 | IVZ | Deferred Share Award - Time Vesting | Common Shares | $0.00 | · | 1,616 | Disposed |
| Nov. 30, 2007 | IVZ | Deferred Share Awards - Time Vesting | Common Shares, par value $0.20 per share | $0.00 | · | 2,680 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 25, 2009 | IVR | Common Stock, par value $0.01 per share | 0 | Direct |
| July 30, 2007 | IVZ | Ordinary Shares, par value $0.10 per share | 1,050 | Direct |
| July 30, 2007 | IVZ | Ordinary ShareS, par value $0.10 per share [F1] | 25,427 | Direct |
| July 30, 2007 | IVZ | Deferred Share Awards-Time Vesting | 2,680 | Direct |
| July 30, 2007 | IVZ | Deferred Share Awards-Time Vesting | 3,233 | Direct |
| July 30, 2007 | IVZ | Options to Purchase - Time Vesting | 61,960 | Direct |
| July 30, 2007 | IVZ | Options to Purchase - Performance Vesting | 10,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $493,585 | · | · | · | $1,800,000 | · | $90,808 | $5,424,332 |
| 2013 | $469,790 | · | · | · | $1,525,017 | · | $346,359 | $4,666,135 |
| 2012 | $440,969 | · | · | · | $874,691 | · | $223,981 | $4,389,624 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.